Big Pharma hits back at watchdog

Big Pharma hits back at watchdog

NCPE expert said 95 per cent of new cancer drugs were bad value

The pharmaceutical sector has attacked claims by the medicines watchdog that expensive cancer drugs are not delivering.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events
  • Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
  • Access to The Business Post's extensive archive‚Äč

Related Articles

More from The Business Post